453 related articles for article (PubMed ID: 19357124)
1. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia.
Smoot LB; Obler D; McElhinney DB; Boardman K; Wu BL; Lip V; Mullen MP
Arch Dis Child; 2009 Jul; 94(7):506-11. PubMed ID: 19357124
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].
Fujiwara M; Yagi H; Matsuoka R; Saji T
Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722
[TBL] [Abstract][Full Text] [Related]
4. ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension.
Eyries M; Coulet F; Girerd B; Montani D; Humbert M; Lacombe P; Chinet T; Gouya L; Roume J; Axford MM; Pearson CE; Soubrier F
Clin Genet; 2012 Aug; 82(2):173-9. PubMed ID: 21651515
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).
Cottin V; Dupuis-Girod S; Lesca G; Cordier JF
Respiration; 2007; 74(4):361-78. PubMed ID: 17641482
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
[TBL] [Abstract][Full Text] [Related]
7. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T
Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic children with hereditary hemorrhagic telangiectasia: a pediatric center experience.
Mei-Zahav M; Letarte M; Faughnan ME; Abdalla SA; Cymerman U; MacLusky IB
Arch Pediatr Adolesc Med; 2006 Jun; 160(6):596-601. PubMed ID: 16754821
[TBL] [Abstract][Full Text] [Related]
9. Genetic basis of pulmonary arterial hypertension: current understanding and future directions.
Newman JH; Trembath RC; Morse JA; Grunig E; Loyd JE; Adnot S; Coccolo F; Ventura C; Phillips JA; Knowles JA; Janssen B; Eickelberg O; Eddahibi S; Herve P; Nichols WC; Elliott G
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):33S-39S. PubMed ID: 15194176
[TBL] [Abstract][Full Text] [Related]
10. Hereditary hemorrhagic telangiectasia is caused by the Q490X mutation of the ACVRL1 gene in a large Arab family: support of homozygous lethality.
El-Harith el-HA; Kühnau W; Schmidtke J; Gadzicki D; Ahmed M; Krawczak M; Stuhrmann M
Eur J Med Genet; 2006; 49(4):323-30. PubMed ID: 16829353
[TBL] [Abstract][Full Text] [Related]
11. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.
Rigelsky CM; Jennings C; Lehtonen R; Minai OA; Eng C; Aldred MA
Am J Med Genet A; 2008 Oct; 146A(19):2551-6. PubMed ID: 18792970
[TBL] [Abstract][Full Text] [Related]
12. Genetics of pulmonary arterial hypertension: current and future implications.
Elliott CG
Semin Respir Crit Care Med; 2005 Aug; 26(4):365-71. PubMed ID: 16121312
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of angiogenesis related proteins and its implication in type-2 hereditary hemorrhagic telangiectasia].
Peng HL; Hu GY; Zhang GS; Gong FJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):616-20. PubMed ID: 17278429
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and screening of ACVRL1 gene in II hereditary hemorrhagic telangiectasia].
Jia JJ; Zhang J; Zhao LD; Zhou XJ; Cheng J; Yuan HJ; Wang HT
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1107-11. PubMed ID: 22781769
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood.
Harrison RE; Berger R; Haworth SG; Tulloh R; Mache CJ; Morrell NW; Aldred MA; Trembath RC
Circulation; 2005 Feb; 111(4):435-41. PubMed ID: 15687131
[TBL] [Abstract][Full Text] [Related]
16. Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1.
Mache CJ; Gamillscheg A; Popper HH; Haworth SG
Thorax; 2008 Jan; 63(1):85-6. PubMed ID: 18156574
[TBL] [Abstract][Full Text] [Related]
17. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
[TBL] [Abstract][Full Text] [Related]
18. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.
Bossler AD; Richards J; George C; Godmilow L; Ganguly A
Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392
[TBL] [Abstract][Full Text] [Related]
19. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5.
Cole SG; Begbie ME; Wallace GM; Shovlin CL
J Med Genet; 2005 Jul; 42(7):577-82. PubMed ID: 15994879
[TBL] [Abstract][Full Text] [Related]
20. Clinical and genetic characteristics of Chinese patients with hereditary haemorrhagic telangiectasia-associated pulmonary hypertension.
Chen YJ; Yang QH; Liu D; Liu QQ; Eyries M; Wen L; Wu WH; Jiang X; Yuan P; Zhang R; Soubrier F; Jing ZC
Eur J Clin Invest; 2013 Oct; 43(10):1016-24. PubMed ID: 23919827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
